References
Kashani, B. N., Centini, G., Morelli, S. S., Weiss, G., & Petraglia, F. (2016). Role of medical management for uterine leiomyomas. Best Practice & Research Clinical Obstetrics & Gynaecology, 34, 85-103. Akinola, L. A., Okohue, J., Ikechebelu, J., Alabi, C. O., & Olumodeji, A. M. (2021). Approach to Management of Submucous Fibroids by Gynaecological Endoscopy Surgeons/Trainees in Nigeria. African Journal of Reproduction and Gynaecological Endoscopy, 6(1), 1-9. Okogbo, F. O., Ezechi, O. C., Loto, O. M., & Ezeobi, P. M. (2011). Uterine Leiomyomata in South Western Nigeria: a clinical study of presentations and management outcome. African Health Sciences, 11(2). Ezeama, C. O., Ikechebelu, J. I., Obiechina, N. J., & Ezeama, N. N. (2012). Clinical Presentation of Uterine Fibroids in Nnewi, Nigeria: A 5. year Review. Annals of medical and health sciences research, 2(2), 114-118. Ekine, A. A., Lawani, L. O., Iyoke, C. A., Jeremiah, I., & Ibrahim, I. A. (2015). Review of the clinical presentation of uterine fibroid and the effect of therapeutic intervention on fertility. Am J Clin Med Res, 3(1), 9-13. Oluwole, A. A., Owie, E., Babah, O. A., Afolabi, B. B., & Oye-Adeniran, B. A. (2015). Epidemiology of Uterine Leiomyomata at the Lagos University Teaching Hospital, Idi- Araba, Lagos. Nigerian Hospital Practice, 15(1-3), 14-20. Senbanjo, O. C., Ottun, T. A., Akinlusi, F. M., Oshodi, Y. A., Rabiu, K. A., & Adewunmi, A. A. (2023). Clinical Presentation of Uterine Leiomyoma and the Outcome of Surgical Management Options in a Nigerian Tertiary Health Facility. Annals of Health Research (The Journal of the Medical and Dental Consultants Association of Nigeria, OOUTH, Sagamu, Nigeria), 9(2), 136-145. Asaolu, O. A., Ejenobo, D. T. E., & Alabi, O. A. (2023). Laparoscopic Myomectomy for Huge Uterine Fibroid in Sub-Saharan Africa: A Case Report. African Journal of Reproduction and Gynaecological Endoscopy, 8(1), 32-36. Stewart, E. A., Cookson, C. L., Gandolfo, R. A., & Schulze-Rath, R. (2022). Epidemiology of uterine fibroids: A systematic review. BJOG: An International Journal of Obstetrics & Gynaecology, 129(1).30-39. Styer, A. K., & Rueda, B. R. (2016). The epidemiology and genetics of uterine leiomyoma. Best practice & research Clinical obstetrics & gynaecology, 34, 3-12. Governini, L., Marrocco, C., Semplici, B., Pavone, V., Belmonte, G., Luisi, S., ... & Piomboni, P. (2021). Extracellular matrix remodeling and inflammatory pathway in human endometrium: insights from uterine leiomyomas. Fertility and Sterility, 116(5), 1404- 1414. Shen, Y., Dong, Y. M., Lu, Q., Xu, J., Wu, Y. T., Yun, S. S., & Ren, M. L. (2016). Phenolic environmental estrogens in urine and blood plasma from women with uterine leiomyoma: Epidemiological survey. Journal of Obstetrics and Gynaecology Research, 42(4), 440-445. Alessandrini, L., Astolfi, L., Daloiso, A., Sbaraglia, M., Mondello, T., Zanoletti, E., ... & Marioni, G. (2023). Diagnostic, prognostic, and therapeutic role for angiogenesis markers in head and neck squamous cell carcinoma: a narrative review. International Journal of Molecular Sciences, 24(13), 10733. Bajaj, S., Gopal, N., Clingan, M. J., & Bhatt, S. (2022). A pictorial review of ultrasonography of the FIGO classification for uterine leiomyomas. Abdominal Radiology, 47(1), 341-351. IJMEPR Avwioro, O.G. (2014). Staining In: Histochemistry and tissue pathology principles and techniques, 3rd edition, Claverianum Press Nigeria Limited: 133-168. Zhang, Z., Huang, H., Jiang, K., Liu, W., Xuan, Y., & Lu, W. (2025). Global, regional, and national uterine fibroid burden from 1990 to 2021 and projections to 2050. BMC Women’s Health, 25, 423. Iwuoha, E.C., Uwaegbulam, C.E., Eni, I., & Thomas, J. (2022). Prevalence of Uterine Fibroids Among Women Presenting at Abia State University Teaching Hospital, Abia State: a Five- Year Review. A Medical Journal of Abia State University Medical Students’ Association, 14(1)1-12. Lin, K. Y.-H., Yang, C.-Y., Lam, A., Chang, C. Y.-Y., & Lin, W.-C. (2021). Uterine leiomyoma is associated with the risk of developing endometriosis: A nationwide cohort study involving 156,195 women. PLOS ONE, 16(8), e0256772. Asaturova, A., Zaretsky, A., Rogozhina, A., Tregubova, A., & Badlaeva, A. (2024). Advancements in minimally invasive techniques and biomarkers for the early detection of endometrial cancer: A comprehensive review of novel diagnostic approaches and clinical implications. Journal of Clinical Medicine, 13(24), 7538. Eulálio Filho, W. M. N., Soares, E. A. S., Lima, M. S. O., Brazil, E. D. N., Rodrigues, R. M. M., Zeron, R. M. C., & Costa, P. V. L. (2019). Evaluation of KI-67 expression in uterine leiomyoma and in healthy myometrium: a pilot study. Revista da Associação Médica Brasileira, 65(12), 1459–1463. Raverot, G., Ioachimescu, A., Pivonello, R., Roy, P., Attacks, J., & Corse, C. et al. (2021). Aggressive pituitary tumours and pituitary carcinomas. Nature Reviews Endocrinology, 17(11), 671–684. Kumar, H., Deshwal, A., Datwani, S., & Li, Z. (2025). Decoding high-grade endometrial cancer: A molecular-histologic integration using the cancer genome atlas framework. Journal of Clinical and Translational Pathology, 5(3), 104-113. Eruvwahwe, E. F. E., Alaba, E. U., O. G. E., & Deele, M. B. (2021). Immunohistochemical characterization of genes expressed in leiomyoma using Ki-67 and p53 in patients attending Niger Delta University Teaching Hospital. Journal of Cancer and Tumour International, 11(3), 30–38. Davey, M. G., Hynes, S. O., Kerin, M. J., Miller, N., & Lowery, A. J. (2021). Ki-67 as a prognostic biomarker in invasive breast cancer. Cancers, 13(17), 4455. Yang, Q., Ciebiera, M., Bariani, M. V., Ali, M., Elkafas, H., Boyer, T. G., & Al-Hendy, A. (2022). Comprehensive review of uterine fibroids: developmental origin, pathogenesis, and treatment. Endocrine reviews, 43(4), 678-719. Reuschenbach, M., Vinokurova, S., & von Knebel Doeberitz, M. (2011). HPV-assoziiertes Karzinom des weiblichen Genitaltrakts. Der Pathologe, 32(6), 451-460. Shen, X., Yang, Z., Feng, S., & Li, Y. (2021). Identification of uterine leiomyosarcoma-associated hub genes and immune cell infiltration pattern using weighted co-expression network analysis and CIBERSORT algorithm. World journal of surgical oncology, 19(1), 223. Chen, Y., Xiong, N., Xiao, J., Huang, X., Chen, R., Ye, S., & Tan, X. (2022). Association of uterine fibroids with increased blood pressure: a cross-sectional study and meta- analysis. Hypertension Research, 45(4), 715-721. Thompson, J., Kowalik, A., & Smith, L. (2022). Evaluation of p16 and Ki-67 expression profiles in distinguishing uterine leiomyosarcoma from cellular leiomyoma variants. Journal of Clinical Pathology and Molecular Oncology, 45(2), 112–119. IJMEPR Lee, M., Cheon, K., Chae, B., Hwang, H., Kim, H. K., Chung, Y. J., ... & Kim, M. R. (2018). Analysis of MED12 mutation in multiple uterine leiomyomas in South Korean patients. International journal of medical sciences, 15(2), 124. Radu, P., Zurzu, M., Paic, V., Bratucu, M., Garofil, D., Tigora, A., & Strambu, V. (2023). CD34— Structure, functions and relationship with cancer stem cells. Medicina, 59(5), 938. Kapoor, S., Shenoy, S. P., & Bose, B. (2020). CD34 cells in somatic, regenerative and cancer stem cells: Developmental biology, cell therapy, and omics big data perspective. Journal of cellular biochemistry, 121(5-6), 3058-3069. Stewart, E. A., & Nowak, R. A. (2022). Uterine fibroids: Hiding in plain sight. Physiology, 37, 16– 27. Salas, A., Beltrán-Flores, S., Évora, C., Reyes, R., Montes de Oca, F., Delgado, A., & Almeida, T. A. (2022). Stem Cell Growth and Differentiation in Organ Culture: New Insights for Uterine Fibroid Treatment. Biomedicines, 10(7), 1542. Yin, P., Ono, M., Moravek, M. B., Coon, J. S., Navarro, A., Monsivais, D., & Bulun, S. E. (2015). Human uterine leiomyoma stem/progenitor cells expressing CD34 and CD49b initiate tumours in vivo. The Journal of Clinical Endocrinology & Metabolism, 100(4), E601- E606.
